Abstract
Background:
Over the past decade, opioid overdose deaths have sharply increased. The Social Determinants of Health (SDOH) framework can guide interventions to improve opioid use disorder (OUD) outcomes. No comprehensive review of SDOH interventions and their impacts on OUD outcomes is available. This scoping review addresses that gap.
Methods:
We extracted articles from PubMed, Embase, Web of Science, and Cochrane databases. Interventions were categorized according to SDOH domains: healthcare system, social and community context, neighborhood environment, economic stability, and education. Interventions and OUD outcomes (e.g., treatment initiation, opioid use, overdose) were summarized.
Results:
Twenty-seven peer-reviewed studies targeted SDOH domains. The healthcare system domain (37 % of studies) was the most frequently addressed, focusing on provider training, access, and quality-of-care improvements with outcomes like increased initiation of medication for OUD, reduced opioid use, and reduced provider stigma. Community and social context (30 %) interventions included social support programs and community coalitions that reduced opioid use, overdose, and community-level stigma. Economic stability (16 %) interventions included employment-based reinforcements and financial incentives to promote abstinence. Neighborhood and physical environment (9 %) interventions included Housing-First initiatives that reduced opioid use. In the education domain (2 %), an early education intervention reduced adulthood OUD risk. Over half of all studies (52 %) used randomized designs; the remainder used quasi-experimental approaches. Gaps included a limited range of SDOH interventions, inconsistent definitions and measurements of SDOH, and a lack of rigorous evaluations.
Conclusion:
Future research should harmonize SDOH terminology and metrics, rigorously assess SDOH intervention outcomes, and expand the range of SDOH interventions.
Keywords: Social Determinants of Health, Opioid Use Disorder, Substance-Related Disorder, Health Disparity, United States
1. Introduction
In 2023, approximately 6 million people, representing 3 % of the United States (U.S.) population age 12 years or older, reported an opioid use disorder (OUD) in the past year (Substance Abuse and Mental Health Services Administration, 2024). The toll of opioid-related deaths, which more than tripled from 21,000 in 2010 to over 68,000 deaths in 2020, has disproportionately impacted people of color (Mason et al., 2022; Milam et al., 2021) and people from economically disadvantaged backgrounds (Altekruse et al., 2020; van Draanen et al., 2020). The alarming rate of opioid-related deaths and widening health disparities underscore the need to leverage the Social Determinants of Health (SDOH) framework to understand the conditions that shape the development of OUD and intervene with those conditions to improve OUD outcomes.
SDOHs are defined as “conditions in the environments where people are born, live, learn, work, play, worship, and age” that shape health (Kaiser Family Foundation, 2018; Office of Disease Prevention and Health Promotion, 2024). SDOH domains–education access and quality, economic stability, healthcare access and quality, neighborhood and built environment, and the social and community context–are unevenly distributed in society and result in unequal exposure to factors associated with a variety of health conditions, including OUD (Cockerham et al., 2017; KFF, 2018; National Institute on Drug Abuse, 2023a; Yelton et al., 2022). SDOH factors influence the development, persistence, and outcomes of OUD, influence access to quality healthcare and licensed medical professionals, and affect OUD outcomes, including initiation, remission, and mortality (Abraham et al., 2013; Chang et al., 2022; Han et al., 2022; Hansen et al., 2022; Hser, 2007; Jin et al., 2017; Lin et al., 2024; Lopez et al., 2021; McKenzie et al., 2016; Rangachari et al., 2022; Whitesell et al., 2013; Whittle et al., 2019). See Table 1 for examples of SDOH disparities and OUD risk.
Table 1.
Example of SDOH Conditions and OUD Risk.
| Domain | Domain Examples | OUD Examples | Examples from the Literature |
|---|---|---|---|
| Healthcare system | Quality of care, provider availability, linguistic and cultural competency, and healthcare coverage. | quality of OUD treatment, provider negative bias about people with OUD, access to evidence-based OUD treatments, access to medication for opioid use disorder, systematic and consistent referrals to appropriate levels of care. | Medications for OUD are likely in treatment programs that have greater medical resources and funding (Abraham et al., 2020; Knudsen and Roman, 2014). |
| Education | Education attainment, early child education, vocational training, and higher education | early childhood education, vocational supports, access to or achievement of higher education | Adults who did not attend college have disproportionately high rates of substance use disorders (Braveman, 2023). |
| Community and social context | Social integration, support systems, community engagement, discrimination, and stress. | Family, neighborhood, mutual aid and other social support systems, engagement or reentry social supports, discrimination, stress, isolation, stigma. | Social support as well as living in communities with social cohesion and community beneficence is associated with lower rates of OUD (Avery et al., 2021; Dasgupta et al., 2018; Hser, 2007; Warren et aL, 2007). |
| Economic Stability | Employment, income, expenses, debt, medical bills, and economic support. | Supports for supplemental income, expenses, debt, medical bills, and other economic supports. | Adults who are unemployed have disproportionately high rates of substance use disorders (Braveman, 2023) whereas employment is associated with OUD recovery (Hser et al,, 2015) |
| Neighborhood and physical environment | Housing, transportation, safety, access to playgrounds, parks, walkability and zip code or geographic location. | Transportation options, availability and cost of housing, safety/violence, geographic setting (i.e., rurality). | Risk of fentanyl-involved overdose death varies by neighborhood disadvantage (Wagner et al., 2021). Patients living in rural areas vs. urban residents have greater challenges in accessing OUD treatment due to lower specialized treatment options, longer travel time to treatment facilities, higher economic burden, and less health insurance (Bond Edmond et al., 2015; Kiang et al., 2021). |
Domain examples column are from Kaiser Family Foundation. (2018). Beyond health care: The role of social determinants in promoting health and health equity. https://www.kff.org/racial-equity-and-health-policy/issue-brief/beyond-health-care-the-role-of-social-determinants-in-promoting-health-and-health-equity/
Understanding interventions that target SDOH and assessing their association with OUD outcomes can provide critical insights to meet the needs of individuals at risk of developing OUD or who are diagnosed with OUD. However, comprehensive reviews that explore how SDOH interventions affect OUD outcomes are sparse. For example, Sugarman and colleagues (2020) found that evidenced-based interventions addressing OUD and SDOH were lacking among people experiencing incarceration (Sugarman et al., 2020). Formosa and colleagues (2019) summarized the evidence of SDOH interventions for patients experiencing homelessness yet limited their review to emergency department (ED) settings and did not specifically focus on OUD (Formosa et al., 2019).
To address the gaps in knowledge about SDOH and their influence on OUD-related outcomes, the present work conducted a scoping review (Munn et al., 2018) to examine SDOH interventions in the context of OUD across multiple settings and populations. Specifically, this review uses an SDOH framework to identify, evaluate, and synthesize the current knowledge of SDOH interventions and their impacts on OUD outcomes. To this end, the research questions are: Toward improving OUD outcomes, what interventions have been implemented to change factors across the SDOH domains (i.e., interventions on education, economic stability, healthcare access and quality, neighborhood or physical environment, and social and community context, as well as economic stability)? What are the outcomes of these SDOH interventions? What are the strengths and weaknesses in SDOH-focused interventions? This review is timely as the 2022–2026 NIDA strategic plan calls for research on the impact of SDOH on substance use, treatment utilization, outcomes, and recovery, as well as research on interventions that target SDOH factors to help achieve more equitable OUD outcomes (National Institute on Drug Abuse, 2023a; Volkow, 2023).
2. Methods
We defined an SDOH intervention as a program or policy seeking to improve OUD outcomes by addressing the social, economic, and environmental conditions that contribute to OUD and its consequences. Using the KFF and Healthy People 2030 frameworks (Kaiser Family Foundation, 2018; Office of Disease Prevention and Health Promotion, 2024), we summarized interventions by SDOH domains: (1) education; (2) healthcare system; (3) economic stability; (4) neighborhood and physical environment; and (5) community, safety, and social context. SDOH are often conceptualized as upstream factors (e.g., improving social conditions through addressing root causes at the society or community level). However, to provide a comprehensive review of SDOH interventions, similar to work by others (Whitman et al., 2022), we did not exclude interventions at the mid-level (e.g., individual-level needs from broader societal conditions) or downstream (e.g., address immediate social needs at the individual level)
This literature review was also guided by elements of the Preferred Reporting Items for Systematic Reviews and Meta-analyses 2020 guidelines. The protocol is pending review with Open Science Framework (https://osf.io/6b7q4).
2.1. Search strategy
Informational databases included PubMed, Embase, Web of Science, and Cochrane Review. The search included articles published between 2013 and 2024, focusing on studies conducted in the U.S. The cutoff day of the search was September 10, 2024. The timeframe sought to capture the most recent shifts in substance use patterns and contemporary developments in OUD research and intervention effectiveness. The search strategy combined the search terms from key concepts, including intervention studies (e.g., intervention trial, randomized controlled (RCT) trial, pragmatic clinical trial, evaluations) and opioid use (e.g., opioid or heroin use, opioid-related disorders, etc.) as well as SDOH terms (i.e., social determinants, or specific factors within education, health care and quality, economic stability, neighborhood or physical environment, and social and community context domains of the SDOH). The search terms (see Appendix) were reviewed by a librarian and included MeSH, title, abstract, and keywords to ensure thoroughness. A hand search conducted on Google Scholar supplemented the results. Records were imported into Mendeley Reference Manager for deduplication.
2.2. Screening criteria
After removing duplicates (N = 468), 676 articles potentially met the initial eligibility criteria. Abstracts and titles were screened using Rayyan, a cloud-based web app developed for systematic reviews (Ouzzani et al., 2016). Exclusion criteria included 1) studies conducted outside of the United States; 2) article not in English; 3) full article not available; 4) not human subjects; 5) outcomes unrelated to opioid use or OUD, not disaggregated, or were related to pain management or surgery; 6) no intervention described (e.g., cross-sectional studies describing associations with SDOH); 7) intervention not targeting SDOH domains or factors; 8) wrong publication type (e.g., protocols, reviews, editorials, opinions) and 9) sample size was less than 20 individuals.
2.3. Data extraction and analysis
From abstract and title screening, 62 studies potentially met eligibility criteria (Fig. 1). Full texts were imported into Atlas.ti (Version 22.0) for content analysis. Initial codes were developed to characterize SDOH interventions (guided by the KFF SDOH framework), study design, targeted population, setting, intended outcomes (e.g., opioid use, access to treatment, overdose prevention) and main findings. The priori codes evolved throughout the coding process to capture additional SDOH elements and emerging themes. Five Ph.D. or Master-level researchers with research experience in OUD and SDOH conducted screening and coding. Thirty-five articles were excluded due to not having an SDOH-related intervention, wrong study design, outcome not related to opioid use or OUD, full text unavailable, not in the U.S., or the study population was under 18 years old. We categorized 27 articles according to SDOH domain, study design, SDOH intervention strategy location, setting, population, and outcomes. Two coders reviewed each article at each phase, and coding discrepancies were resolved through consensus meetings.
Fig. 1.

Flowchart Outlining Search Strategy.
3. Results
3.1. Study characteristics
Two-thirds (67 %) of the articles were published in 2020 or later; the rest were published earlier. Over half (52 %, n = 14) of the articles included randomization, while 48 % (n = 13) were quasi-experimental designs (Table 2). Most studies (81 %) focused on individuals using opioids or with OUD. Interventions were primarily conducted in healthcare settings (52 %), with fewer in community (44 %), and school settings (4 %). Common study locations included Massachusetts (15 %) and New York, North Carolina, Maryland, Ohio, Pennsylvania and Washington (each 7 %). More than a third (37 %) of studies focused on the SDOH domain of healthcare quality and systems, followed by 30 % addressing community and social context, 16 % focusing on economic stability (9 % on neighborhood and physical environment, and only one article explored the education domain.
Table 2.
Characteristics of Included Studies.
| N (%) | |
|---|---|
| SDOH Domains | |
| Healthcare system | 16 (37 %) |
| Community and social context | 13 (30 %) |
| Economic Stability | 7 (16 %) |
| Neighborhood and physical environment | 4 (9 %) |
| Education | 1 (2 %) |
| Settings | |
| Healthcare settings | 14 (52 %) |
| Community settings | 12 (44 %) |
| School settings | 1 (4 %) |
| Populations | |
| People in jeopardy of developing OUD | 8 (21 %) |
| People with OUD | 22 (60 %) |
| Providers or other staff | 7 (18 %) |
| Study Design | |
| Randomized Controlled Trial | 14 (52 %) |
| Quasi-experimental design two group design | 3 (11 %) |
| Quasi-experimental one group, post-test only, etc. | 10 (37 %) |
Note: Articles covered multiple domains of SDOH (n = 41) and multiple populations (n = 37) therefore do not add up to 27.
3.2. Healthcare system domain
Over a third of the studies of interventions that focused on the healthcare system domain (38 %) included randomization in their design. Interventions in this domain aimed to enhance healthcare quality and access through changing provider knowledge and practice, implementing clinical guidelines for opioid medications, coordinating access to care, and reducing stigma. However, it is important to note that some of these interventions were both upstream SDOH (social/structural influences) and direct medical care interventions. See Tables 3, 4 and 5.
Table 3.
Study Design by SDOH Domains.
| N (%) | |
|---|---|
| SDOH Domains | |
| Healthcare system (n = 16) | |
| Randomized controlled trial | 6 (38 %) |
| Quasi-experimental (two-group design) | 2 (12 %) |
| Quasi-experimental (one-group design) | 8 (50 %) |
| Community and social context (n = 13) | |
| Randomized controlled trial | 3 (23 %) |
| Multi-site, community-level, cluster-randomized trial | 2 (15 %) |
| Quasi-experimental (two-group design) | 1 (8 %) |
| Quasi-experimental (one-group design) | 7 (54 %) |
| Economic Stability (n = 7) | |
| Randomized controlled trial | 4 (57 %) |
| Quasi-experimental (one-group design) | 3 (43 %) |
| Neighborhood and physical environment (n = 4) | |
| Quasi-experimental (one-group design) | 4 (100 %) |
| Education (n = 1) | |
| Randomized controlled trial | 1 (100 %) |
Note: Articles covered multiple domains of SDOH (n = 41) therefore the overall design types do not add up to 27.
Table 4.
Summary of Eligible Articles (N = 27).
| Article | Design | Intervention Strategies | SDOH Domains | Population | Setting | Location | Outcomes | Main findings |
|---|---|---|---|---|---|---|---|---|
| Alexandridis et al., (2019) | Quasi-experimental. Interrupted time series comparing before and after implementation (one group design) | Community support systems Healthcare-provider training, expansion of addiction treatment Emergency department policy revision to limit opioid analgesics prescription | Community and social context; Healthcare system | Community general population Buprenorphine patients Prescribers within 100 counties over 2009–2014 (N = 7200 county-months) | 74 counties | North Carolina | Not reduced prescribing of opioid analgesics. Not decreased buprenorphine utilization. | Implementation of Project Lazarus (PL), a seven-strategy, community-coalition-based intervention, did not appreciably reduce opioid dispensing or increase buprenorphine utilization. |
| Crowthers et al., (2022) | Quasi-experimental. One group pretest posttest. | Peer recovery coaching which covered living and financial independence, employment and education, relationships and social support, and independence from legal involvement and institutions | Economic stability; Neighborhood/physical environment; Community and social context; Healthcare system | Male patients with SUD and/or co-occurring mental health disorder (N = 117). | Maryville Addiction Treatment Centers | New Jersey | A higher rate of abstinence. Increased housing stability. Lower mental health and behavioral/social consequences. Longer participant-recovery coach exposure time and higher follow-up rates. | Patients paired with a recovery coach extensively trained in MOUD can achieve a variety of desired outcomes such as higher drug abstinence, increased housing stability, improved treatment retention, and reduced negative health and social consequences. |
| Dahlem et al., (2021) | Quasi-experimental. One group pretest posttest. Pilot intervention. | Peer recovery coach supporting housing, transportation, clothing, insurance, food stamps, household items, phone, identification cards, insurance, and referral to treatment services | Economic stability; Neighborhood and physical environment, Food, Community and social context, Healthcare system | Patients who experienced non-fatal overdose (N = 122). | Community setting involving local crisis team, law enforcement agencies, SUD/mental health treatment facilities, and ED | Washtenaw County, Michigan | Among 122 overdose survivors, 77.0 % were engaged, 33.6 % (n = 41) received ongoing treatment services, one participant received recovery housing, three (2.5 %) were incarcerated and three (2.5 %) were deceased, and 75 (61.5 %) declined services. | The community-wide coordinated program in the EDs showed promise in linking overdose survivors to recovery support and treatment services post-overdose. |
| Davidson et al., (2014) | Quasi-experimental. One group pretest posttest. Feasibility study. | Supportive housing using participant involvement (“consumer-participation”) for chronically homeless individuals whose substance use is a primary barrier to independent housing. Providers were expected to follow a Housing First approach for providing client-centered supportive services to improve retention. | Neighborhood and physical environment | Individuals with histories of chronic homelessness and problematic substance use (N = 358). | Community setting: 500 units of apartments | New York City, New York | Fidelity in implementation of supportive housing components and client substance use was not related. However, clients in participant involvement (or “consumer participation-consistent programs”) “ were less likely than others to report using stimulants or opiates at follow-up. | Clients in programs with greater fidelity to participant involvement components of Housing First were more likely to be retained in housing and were less likely to report using stimulants or opiates at follow-up. |
| Davis et al., (2024) | Multi-site, parallel-group, cluster-randomized, waitlist-controlled trial | Utilized a Communities that HEAL (CTH) intervention on perceived opioid-related community stigma by stakeholders in the HEALing Communities Study (HCS). Communities selected CTH interventions from a menu of options based on their existing resources, needs, and service gaps, thus, EBPs varied by community | Community and social context | Adult community coalition members and key stakeholders in the 66 Intervention and Wait-list Control HCS (N = 1385). There were 1385 coalition stakeholders in the sample, representing all 66 participating communities. The substance use sector represented 47 % of all sectors. | Community setting | 67 communities in four states-Massachusetts, New York, Ohio), and Kentucky ( | Intervention stakeholders reported a larger decrease in perceived community stigma toward people treated for OUD (adjusted mean change (AMC) −3.20 [95% C.I. −4.43, −1.98]) and toward MOUD (AMC − 0.33 [95% C.I. −0.56, −0.09]) than stakeholders in Wait-list Control communities (AMC −0.18 [95 % C.I. −1.38, 1.02], p = 0.0007 and AMC0.11 [95% C.I. −0.09, 0.31], p = 0.0066). The relationship between intervention status and change in stigma toward MOUD was moderated by rural-urban status (urban AMC −0.59 [95 % CI, −0.87, −0.32], rural AMC not sig.) and state. | The CTH intervention decreased stakeholder perceptions of community stigma toward people treated for OUD and stigma toward MOUD. Implementing CTH intervention in other communities could decrease OUD stigma across diverse settings nationally |
| Deshazer et al., (2020) | Quasi-experimental retrospective study with pre-post intervention study | To reduce access to opioids the study conducted Quality management-focused reducing over prescribing of opioids. For those circumstances where opioids were indicated, implement tools and controls to encourage safe prescribing of opioids consistent with the CDC guidelines and de-escalating protocols for those on high doses (secondary prevention). Among those with OUD, offered interventions to support a lasting recovery (Tertiary prevention) | Healthcare system | Records from OUD diagnosed commercial members per year (N = 9700). | Healthcare (national health plan) and community setting involving local, state, and federal agencies; local school districts; businesses; law and drug enforcement; and community-and faith-based organizations | Delaware, Pennsylvania, West Virgina | A 19 % decrease across the eligible Highmark membership of total opioid prescription fills normalized per 1000 members. A 15 % decrease was observed between 2016 and 2017, and this was a sharper decrease than observed in previous years between 2013 and 2016. In terms of RX fills by geography, the results varied by state between 2016 and 2017, with the biggest decreases in WV and PA at 16 % each and 10 % in | Reduced total Opioid RX fills, opioid use by dose and duration for members diagnosed with OUD. A decrease of 19 % of total Opioid RX fills; shorter durations and the majority of these members switched to 7 days or less of opioid use; and a reduction by 13 percentage point of the number of members on higher strength 20 + MMEs opioids resulted. |
| Glasgow, et al., (2024) | Multi-site, parallel-group, cluster-randomized, waitlist-controlled trial | The Communities That HEAL (CTH) intervention, a multi-site, community-level, cluster randomized waitlist controlled trial, seeks to reduce opioid overdose deaths through evidence-based practices, community engagement, and health communication campaigns in 67 highly impacted communities to increase access to behavioral health access | Community and social context | 67 communities in four states | Community setting | 67 communities in four states-Massachusetts, New York, Ohio), and Kentucky ( | No significant differences were detected between intervention and waitlisted communities in the rate of individuals receiving any of the five BHS categories. None of the interaction effects used to test the effect modification were significant. | No significant intervention effects were observed through Medicaid claims data, the best available data source but limited in terms of capturing individuals reached by the intervention. Also, the 12-month evaluation window may have been too brief to see improved outcomes considering the time required to stand-up BHS. |
| Godwin and Conduct Problems Prevention Research Group, (2020) | Randomized controlled trial | Fast Track (FT), a comprehensive childhood intervention designed to decrease aggression and delinquency in at-risk kindergartener by targeting children’s intrapersonal, interpersonal, and academic skills and their parents’ parenting skills and behaviors through two intervention phases: elementary (grades 1–5) and secondary (grades 6–10) school. | Education, Community and Social Connectedness | Participants (N = 713) from high-risk elementary schools (N = 55) based on neighborhood level crime and poverty. | School setting involving elementary schools and parent-child relationships | Durham, North Carolina; Nashville, Tennessee; rural Pennsylvania; and Seattle, Washington | During young adulthood (ages 19–25), control participants more often reported weekly use of opioids in the past 12 months compared to intervention participants. Intervention significantly decreased the probability of opioid use by 61.2 %. Control participants more often reported hazardous drinking between ages 15 and 25, compared to intervention youth. Intervention significantly decreased the probability of hazardous drinking by 45.3 %. | Intervention improvements to interpersonal skills (e.g., prosocial behavior, authority acceptance) are the strongest indirect pathway to reduce harmful behaviors (despair, suicide ideation, self-harm, hazardous drinking, opioid use). |
| Gryczynski et al., (2021) | Two group parallel randomized trial | Intervention group consisted of patient navigators to conduct proactive case management, advocacy, service linkage, and motivational support to resolve internal and external barriers to care and address medical and basic needs (such as food, housing, clothing, and transportation) | Economic stability, Healthcare system | Hospitalized adults with comorbid SUDs of opioid, cocaine, or alcohol (N = 400). | Healthcare - A large urban academic medical hospital with an SUD consultation service | Baltimore, Maryland | Participants in the navigator intervention group were less likely to have an inpatient readmission within 30 days compared to participants receiving TAU and were more likely to enter community SUD treatment after discharge/ | Patient navigation reduced inpatient readmissions and ED visits in this clinically challenging sample of hospitalized patients with comorbid SUDs. |
| Hagedorn et al., (2022) | Quasi-experimental. Two group pre/post test with block randomization. | Healthcare - Quality improvement - assessment of local barriers/facilitators, formation of a local implementation team, a site visit for action planning and training/education, cross-facility quarterly calls, monthly coaching calls, and consultation. | Healthcare system | VHA facilities (N = 35). | Healthcare - Veteran Health Administration facilities in the lowest quartile of performance on the MOUD/OUD ratio among all VHA facilities as of October 2017. | Unknown | Intervention facilities significantly increased the ratio of patients with OUD receiving MOUD from an average of 18 % at baseline to 30 % 1 year later, with an absolute difference of 12 %. | Intensive external facilitation improved the adoption of MOUD in most low-performing facilities and may enhance adoption beyond other interventions less tailored to individual facility contexts. |
| Hershberger et al., (2022) | Randomized control trial | Healthcare quality - Online training simulation of a healthcare encounter utilizing virtual reality immersion | Healthcare system | Clinical and nonclinical health professionals (N = 158). | Health organizations, such as community health centers | Unknown | Among intervention participants, there was an increased level of compassion for the simulated character who was pregnant woman and using opioids. | Simulation online trainings can heighten awareness in the increase of increasing the cultural sensitivity of clinicians in health care professions for improving health equity. |
| Holtyn et al., (2014) | Randomized control trial | Economic stability - Assigned to one of three treatments: Work Reinforcement (work to earn pay), Methadone & Work Reinforcement (enroll in methadone treatment to work and maximize pay), and Abstinence, Methadone & Work Reinforcement conditions (provide opiate-and cocaine-negative urine samples to maximize pay). | Economic stability | Unemployed adults with OUD who use injection drugs and not currently in treatment (N = 98). | Therapeutic workplace at the Johns Hopkins Bayview Medical Center at large hospital | Baltimore, Maryland | Increased enrollment in methadone treatment during induction. Drug abstinence increased as a graded function of the addition of the methadone and abstinence contingencies. Abstinence, Methadone & Work Reinforcement participants more often provided urine samples negative for opiates and cocaine compared to Work Reinforcement participants. Methadone & Work Reinforcement participants provided significantly more cocaine-negative samples than Work Reinforcement participants. | The therapeutic workplace can promote drug abstinence in people who inject drugs and are out-of-treatment . |
| Howard and Clark, (2017) | Quasi-experimental. One group pretest posttest. | Educational intervention for health professionals based on an interprofessional-shared decision making (IP-SDM) model. | Healthcare system | The purposeful sample (N = 45) consisted of health care providers in the obstetrical setting. There was a total of 45 maternal health care providers who received the training. | The purposeful sample (N = 45) consisted of health care providers in the obstetrical setting. There was a total of 45 maternal health care providers who received the training. | Rhode Island | Knowledge about child welfare laws and resources, stigma reduction, and provider referrals to the RI Department of Health’s Healthy Families America Program (HFA). | Increased their knowledge of child welfare laws pertaining to prenatal substance use as well as what community resources might be available to this population of women. Increased referrals to an evidence-based program, Healthy Families America. Stigma was reduced from pre to post training regarding women with substance use disorders. |
| Hyde et al., (2022) | Quasi-experimental prospective cohort design with an historical comparison group. | Post-Incarceration Engagement (PIE) intervention is a peer-based enhancement designed for the VA healthcare for reentry veterans program. Social and emotional support, linkage and referral to healthcare and social services, and role modeling of life skills. | Community and social connectedness. Healthcare system/Access | Veterans postincarceration. PIE group (n = 43) and historical comparison (n = 36). | Veterans postincarceration. PIE group (N = 43) and historical comparison (N = 36). | Massachusetts | No difference in linkage to primary care within 90 days of release, (58 % versus 67 %). Intervention participants were significantly more likely to receive substance use treatment than the comparison group (86 % versus 19 %, p < .0001) and the mean monthly substance use visits was greater in the intervention group (0.96 versus 0.34, p < .007). Engagement in mental health services was greater for the intervention group than the comparison group (93 % versus 64 %, p < .003). There were no significant differences between groups for emergency department use and hospitalization. | Intervention was found to be feasible and contributed to returning citizens’ greater linkage and engagement with substance use, mental health, and other specialty care than a historical comparison group. |
| Kelleher et al., (2021) | Quasi-experimental. One group pretest posttest. Feasibility study. | Housing first: 6-month rent plus utilities and Strength-Based Outreach and Advocacy and prevention interventions focused on HIV and opioids. | Neighborhood-Housing | 18–24 years who were lacking a fixed, regular, stable, and adequate nighttime residence (N = 21). | Community in a Large Midwestern City-recruitment was at a drop-in center for homeless youth. | Columbus, Ohio | A total of 17 youth completed the study (85 % retention), and a high proportion of youth were stably housed at 6-month follow-up. Participation in intervention services was high with an average of 13.57 sessions for advocacy, 1.33 for MI, and 0.76 for HIV prevention. Alcohol use did not change significantly over time. However, drug use, drug use consequences, and cognitive distortions, and the size of youths’ social networks that were drug using individuals decreased significantly. | The Housing First model appeared to be feasible to deliver, and youth engaged in the supportive intervention services. The study demonstrates the potential for an adapted Housing First model to be delivered to youth experiencing homelessness and may improve outcomes, opening the way for larger randomized trials of the intervention. |
| Ly et al., (2024) | Quasi-experimental one group pretest posttest. Pilot study. | Pharmacist-led pilot service in providing more equitable and accessible BUP treatment to individuals residing in Permeant Supporting Housing | Healthcare system | Formally unhoused participants who lived in Permeant Supportive Housing (N = 38) | Permeant Supportive Housing for people with SUD | California | Among the 38 patients, the mean age was 46 years and 16 (42 %) were Black. Engagement with the service was associated with increased treatment adherence, with 14 patients (37 %) achieving ≥ 80 % PDC post-intervention compared to 1 patient (3 %) pre-intervention (p = 0.0009). | A pharmacist-led BUP outreach service was found to increase treatment adherence in individuals residing in PSH over 3 months. Low-barrier BUP treatment models, such as that evaluated in this study, may help provide more equitable and |
| McCarthy et al., (2019) | Randomized controlled trial. Three-arm prospective, randomized controlled pragmatic trial with randomization occurring at the physician level. | Enhanced provider-patient communication through an Electronic Medication Complete Communication (EMC2) Opioid Strategy text reminders to patients to ED patients about newly prescribed opioid pain relievers. Alerts and messages were sent to ED physicians, primary care providers, and pharmacists to counsel patients on safe opioid use. Patients also received text messages on safe opioid use. | Healthcare system | Patients being discharged from an urban academic ED with a new prescription for hydrocodone-acetaminophen (N = 652). | Urban, academic emergency department | Chicago, Illinois | Demonstrated safe opioid use occurred more often in the EMC2 group (adjusted odds ratio [aOR] = 2.46, 95 % confidence interval [CI] = 1.19–5.06), but not the EMC2 + SMS group (aOR = 1.87, 95% CI = 0.90–3.90) compared with usual care. | The study found that the intervention improved increased likelihood of safe use of opioids compared to TAU and increased patient knowledge. However, there was no influence of the intervention on safe medication use among the portion of the sample returning medication diaries. |
| Molfenter et al., (2019) | A cluster randomized control trial | A multi-organizational learning collaborative to reduce barriers to reimbursement and access to buprenorphine. The intervention included three learning sessions at the beginning, mid-point, and end of a 24-month period, with monthly coaching calls in between. Sessions and calls were directed at payers and treatment agencies to support organizational changes and increase buprenorphine access. Used policy levers to activate systems change, strategizing how payers and providers could overcome barriers to treatment access. | Healthcare system | Patients with OUD diagnosis (N = 22295). | Forty-eight of the 53 eligible treatment agencies in the 14 ADAMHS board areas enrolled in the trial. | Ohio | The intervention condition experienced a 3.0-fold increase in the percentage of buprenorphine use by OUD patients during the experimental period (9.5 % baseline; 28.5 % experimental). Comparison ADAMHS boards and their providers experienced a significantly lower increase in percentage of buprenorphine use (10.9 % baseline; 19.6 % experimental) with an adjusted difference-in-differences of 10.3 % (95 % CI [9.9 %, 10.7%]), p < .001). | The payer-provider partnering process increased payers’ ability to request greater use of buprenorphine. Partnering also led to payers helping link providers to financial and non-financial resources needed to remove barriers and develop buprenorphine treatment infrastructure. Coaching technical assistance during phone calls assisted the payers in creating an environment for greater buprenorphine utilization as a percentage of OUD patients. |
| Novak et al., (2022) | Randomized controlled trial | Participants who qualified for Phase 2 were randomly assigned to either the usual care control group or the abstinence-contingent wage supplement group. | Economic-income | Participants were unemployed adults in opioid agonist treatment (N = 91) | Opioid agonist treatment | Baltimore, Maryland | Abstinence-contingent wage supplement participants provided significantly more opiate- and cocaine-negative urine samples than usual care control participants (63.6 % vs. 44.1 %); abstinence-contingent wage supplement participants were also significantly more likely to become employed and live out of poverty than usual care participants during intervention. | Long-term delivery of abstinence-contingent wage supplements can promote drug abstinence and employment, but many patients relapse to drug use and cease employment when wage supplements are discontinued. |
| Palombi et al., (2019) | Quasi-experimental. One group pretest posttest. Feasibility and effectiveness study. | Collaborative teams planned and implemented a series of nine community forums focused on opioid and heroin use across rural northeast Minnesota to educate and unite invested community members on the critical public health issue. | Community and social context | Rural community forums completed surveys to assess measures of growth in knowledge and awareness (N = note stated) | Community forums | Rural northeast Minnesota | Collaborative teams planned and implemented a series of nine community forums focused on opioid and heroin use across rural northeast Minnesota to educate and unite invested community members on the critical public health issue. | Community forums have functioned as an effective grassroots approach to engaging rural community members in opioid use prevention and intervention efforts. |
| Quanbeck et al., (2018) | A randomized controlled trial with matched-pair design. Feasibility, acceptability and effectiveness study. | ‘Systems consultation’ strategy with audit and feedback, academic detailing (face-to-face education), and external facilitation (process management support) to enhance adherence to opioid prescribing guidelines in primary care. Promoted organizational changes to improve care quality through tailored support and systems engineering tools, translating guidelines into a checklist with expert input, forming change teams, and supporting implementation with monthly site visits and teleconference | Healthcare system | Community-based primary care clinics (N = 8) | Primary care clinics | Wisconsin | At 6 months, statistically significant improvements were noted in intervention clinics in the percentage of patients with mental health screens, treatment agreements, urine drug tests, and opioid-benzodiazepine coprescribing. At 12 months, morphine-equivalent daily dose was significantly reduced in intervention clinics compared to controls. | The systems consultation implementation strategy demonstrated feasibility, acceptability, and effectiveness in a study involving eight primary care clinics. This multidisciplinary strategy holds potential to mitigate the prevalence of opioid addiction and ultimately may help to improve implementation of clinical guidelines across healthcare. |
| Schaeffer et al., (2021) | Randomized controlled trial | “Multisystemic Therapy – Building Stronger Families integrates Multisystemic Therapy for Child Abuse and Neglect“ (MST-CAN) and Reinforcement Based Treatment (RBT) as a family-centered intervention delivered by community-based therapists. Intervened in the home, community, and school settings, aiming to improve family dynamics and the broader social environment through parenting skills training and cognitive behavioral therapy. | Community and social context | Families who had an open case with Child Protective Services (N = 98). | Community | Two areas of the state of Connecticut | Parents reported significant declines over time in the number of days they used in the past month. Parents on average were increasingly more likely to report total past-month abstinence from all drugs (p = .002), from alcohol (p = .001), and from cocaine (p = .045). Parents who received MST-BSF were marginally more likely to report total abstinence from opioids (p = .055) and from cocaine (p = .055). | The findings of this study add to previous pilot research supporting the effectiveness of MST-BSF, delivered by community-based therapists, to significantly reduce parental substance misuse and child neglect through a family and ecologically based treatment. |
| Shaffer et al., (2021) | Quasi-experimental. One group pretest posttest. Open pilot design. | MISSION-CJ treatment for justice-involved individuals with COD, including the integration of criminogenic risk and needs assessment, risk-need-responsivity (RNR) informed treatment planning, and materials that promote prosocial thinking and behavior. | Community and Court-justice | Patients in Drug Treatment Courts (DTCs), N = 79 | 2 DTCs | Urban area in Massachusetts | Reductions in illicit substance use. Regarding opioid use, there was a significant effect of time in MISSION-CJ in reducing opioid use (p = 0.0013), and reductions were observed for clients with high engagement in MISSION-CJ unstructured sessions (p = 0.0387). | This pilot study demonstrated that MISSION-CJ could be implemented alongside DTC for a relapsing DTC population with COD to enhance criminal justice and behavioral health outcomes. This study observed high treatment engagement, from baseline to 6-month follow up. |
| Suzuki et al., (2023) | Randomized controlled trial | Utilized peer recovery coaches, to intervene with hospitalized patients with OUD, providing a relapse prevention plan, contact for six months post-discharge contact, encouragement of MOUD adherence, and identifying community resources | Healthcare | Patients with OUD (N = 25) | Hospital | Massachusetts | No significant differences were found in the proportion of participants retained in MOUD treatment at 6 months (38.5 % vs 41.7%, P = 0.87), proportion of participants readmitted at 6 months (46.2 % vs 41.2 %, P = 0.82), or the time to treatment discontinuation (log-rank P = 0.92) or readmission (log-rank P = 0.85). | This pilot trial did not demonstrate that a recovery coach intervention improved MOUD treatment retention compared with treatment-as-usual among hospitalized individuals with OUD. |
| Tuten et al., (2018) | Quasi-experimental design with a comparison group (Two groups). | The intervention of recovery housing is to provide a communal, supervised living environment for individuals with substance use disorders (SUDs). | Community, economic stability Neighborhood and physical environment | Patients (N = 135) with OUD receiving reinforcement-based treatment with or without recovery housing | Community | Maryland | Participants who accessed recovery housing at any point during treatment were more likely to be opioid abstinent (at one, three and six months). | These analyses found no significant group differences on abstinence and employment outcomes, thus suggesting the potential efficacy of providing recovery house along with RBT. |
| Whiteside et al., (2021) | Randomized controlled trial. Pilot Study | Utilized an Emergency Department Longitudinal Integrated Care (ED-LINC) intervention included bedside brief negotiated interviews, overdose education, facilitation MOUD, proactive longitudinal care management, and the use of a health information exchange to improve healthcare access and continuity | Healthcare system | Participants at a large, urban, safety net hospital (N = 40) | Hospital emergency department (ED) | Seattle, Washington | At the end of the 3-month intervention, fewer days of heroin use in the past 30 days. No significant differences over the course of the 6-month investigation. No significant changes for any new MOUD initiation. | ED-LINC intervention did not result in an improvement in illicit opioid used and MOUD initiation. |
| Yoo et al., (2022) | Randomized control trial with parallel groups. | Randomly assigned to receive either a substantial ($333) or a nominal ($20) monthly cash gift during the early years of the infant’s life. | Economic stability | Low-income mothers in the U.S. with newborns were recruited from hospitals shortly after the infant’s birth (N = 1000) | Community | Nationwide | The cash gift difference of $313 per month had small and statistically nonsignificant impacts on group differences in maternal reports of substance use and household expenditures on alcohol or cigarettes. The estimated share of the $313 group difference spent on alcohol and tobacco was less than 1 %. | Cash gifts do not impact opioid use. |
Table 5.
Description of Articles by Domains.
| SDOH Domain | Focus | Author(s) & Year | Sample Size | Intervention | Key Results |
|---|---|---|---|---|---|
| Healthcare System | Provider knowledge and practice | Alexandridis et al., (2019) | 4 counties | Multifaceted community-coalition-based intervention featuring healthcare-provider training and expansion of addiction treatment | n.s. reduction in prescribing of opioid analgesics n.s. decrease buprenorphine utilization |
| Deshazer et al., (2020) | 9700 patient records | Quality management-focused interventions | ↓ prescription opioid fills by 19 % 84 % of members used opioids prescriptions for ≤ 7 days ↓13 percentage points in use of higher strength opioids |
||
| Howard and Clark, (2017) | 45 obstetrical health professionals | Training for obstetrical health professionals | ↑ knowledge of community supports by 38 %. | ||
| McCarthy et al. (2019) | 126 ED providers serving 652 patients | ED intervention to alert physicians to council patients on safe opioid use | ↑ safe opioid use occurred more often in the consult group (aOR 2.46, CI 1.19, 5.06) and consult plus text reminders to patients (aOR 1.87, 0.90–3.90) vs. TAU | ||
| Quanbeck et al., (2018) | 8 community-based primary care clinics | Quality improvement to implement clinical guidelines on opioid prescribing | 80 % of staff endorsed being familiar with guidelines for safe opioid prescribing |
||
| Whiteside et al., (2021) | 40 PWOUD | ED intervention with case management and education | n.s. difference in opioid use (IRR: 1.50) ↑ MOUD initiation (50 % vs. 30 %) |
||
| Quality assurance and treatment access | Crowthers et al., (2022) | 117 PWOUD | Peer recovery coaching featuring medical services and insurance services referrals | ↑ rate of abstinence (X2=20.0) | |
| Dahlem et al., (2021) | 122 patients who experienced non-fatal overdose | Community case management navigators and peer coaches | 33.6 % received ongoing treatment services | ||
| Gryczynski et al., (2021) | 400 patients with co-occurring SUDs | Patient navigators in hospitals | Faster entry into treatment ↑ SUD treatment entry within 3 months (50.3 % intervention vs 35.3 % TAU) Faster entry into treatment ↑ MOUD treatment entry within 3 months (68 % intervention vs 40 % TAU) ↓ positive opioid drug test within 6 months (68 % vs 74 % TAU) |
||
| Hagedorn et al., (2022) | 35 facilities | Quality improvement interventions to remove barriers | ↑ patients receiving MOUD (18–30 %) 1 year later, with an absolute difference of 12 % | ||
| Hyde et al., (2022) | 43 previously incarcerated veterans | Post-incarceration peer-based intervention with linkage to care | ↑ linkage and engagement in substance use (86 % vs. 19 %), mental health (93 % vs. 64 %) | ||
| Ly et al., (2024) | 38 PWOUD | Pharmacist-led buprenorphine outreach services at Permanent Supportive Housing for people with OUD | ↑ treatment adherence among intervention group (37 % post-intervention vs. 3 % pre-intervention, achieved 80 % of prescription days filled) | ||
| Molfenter et al., (2019) | 48 facilities serving 22,295 patients with OUD | Quality improvement interventions with coaching calls to reduce barriers | ↑ Threefold increase in patients receiving buprenorphine | ||
| Shaffer et al., (2021) | 79 individuals in Drug Court | Wrap-around services to establish links to behavioral health and other prosocial supports | ↓ opioid use ↓ nights in jail |
||
| Suzuki et al., (2023) | 25 hospitalized patients with OUD | Recovery coaches initiated during hospitalization | n.s. MOUD retention vs. TAU (38.5 % vs 41.7 %, p > .05) n.s., readmitted (46.2 % vs 41.2 %, p = 0.82) n.s., time to treatment discontinuation (log-rank, p = 0.92) n.s., readmission (log-rank, p = 0.85) |
||
| Stigma in healthcare settings | Howard and Clark, (2017) | 45 providers | Training for obstetrical health professionals | ↓ negative bias toward substance-using women by 73 %. ↑ knowledge of community resources for OUD risk patients 7.8 % increase |
|
| Hershberger et al., (2022) | 178 health professionals | VR training simulation | n.s. differences in overall bias scale ↓ frustration and ↑ compassion scores for pregnant women who use opioids (mean differences of −.45 and −.31). |
||
| Education | Early education | Godwin and Conduct Problems Prevention Research Group, (2020) | 713 at-risk kindergarteners | Social and emotional development, parenting, children’s skills & behaviors | Weekly opioid use in past 12 months during ages 19–25: Control: 4.1 % Intervention: 1.7 % ↓ probability of opioid use by 61 % |
| Community and social context | Community context and coalitions | Alexandridis et al., (2019) | 4 counties | Multifaceted community-coalition-based intervention featuring healthcare-provider training, expansion of addiction treatment | ↑ dispensing of opioid analgesics (IRR: 1.06). n.s. reduction in the prescribing of opioid analgesics No change in buprenorphine utilization (IRR: 0.98). |
| Davis et al., (2024) | 1385 coalition stakeholders, representing 66 of 67 communities. | Communities That Heal (CTH), containing evidence-based practices, community engagement, and health communication campaigns | ↓ community stigma toward people treated for OUD ↓ community stigma toward people treated for MOUD |
||
| Glasgow et al., (2024) | 67 communities in four states | CTH containing evidence-based practices, community engagement, and health communication campaigns | ↑ access to therapies for OUD by 25 % | ||
| Palombi et al., (2019) | Unknown | Grassroots coalition forums to increase awareness of overdose | ↑development of community-level goals to address OUD | ||
| Social context, integration, reentry, and social supports | Crowthers et al., (2022) | 117 PWOUD | Peer recovery coaching featuring social supports | ↑ rate of abstinence (X2=20.0) ↓ mental health and behavioral/social consequences(X2=41.0). n.s. increase in feeling socially connected from 90.0 % to 98.0 % (X2=2.67). |
|
| Dahlem et al., (2021) | 122 patients who experienced non-fatal overdose | Community case management navigators and peer coaches | 33.6 % received ongoing treatment services | ||
| Hyde et al., (2022) | 43 previously incarcerated veterans | Post-incarceration peer-based intervention | ↑ linkage and engagement in substance use (86 % vs. 19 %), mental health (93 % vs. 64 %) | ||
| Shaffer et al., (2021) | 79 individuals in Drug Court | Prosocial behavior intervention | ↓ opioid use ↓ nights in jail |
||
| Tuten et al., (2018) | 135 individuals with OUD | Psychosocial treatment featuring social clubs | ↑abstinence at 6-months (slope: −0.56) | ||
| Family context | Godwin and Conduct Problems Prevention Research Group, (2020) | 713 at-risk kindergarteners | Social and emotional development, parenting, children’s skills & behaviors | ↓ opioid use later in life following a comprehensive childhood intervention | |
| Schaeffer et al., (2021) | 98 PWOUD | Comprehensive community treatment | ↓ in days spent using opioids over time among parents (slope: −0.34) ↑ likely to report total past-month abstinence from all drugs (slope: −0.06) ↑ likely for past-month abstinence from opioids (slope: −1.45, p = 0.055) |
||
| Economic Stability | Employment | Crowthers et al., (2022) | 117 PWOUD | Peer recovery coaching | ↑ rate of abstinence (X2=20.0) ↑ employment (X2= 19.17) |
| Holtyn et al., (2014) | 98 PWOUD | Employment-based reinforcement in therapeutic workplace for drug abstinence | 92 % of participants engaged in methadone treatment 75 % negative opiate urine samples vs. 54 % in work reinforcement only group | ||
| Novak et al., (2022) | 91 PWOUD | Abstinence-contingent wage supplements vs. TAU for drug abstinence and employment | ↑ higher opiate and cocaine-negative urine samples in participants enrolled in contingent-wage vs. TAU (63.6 % of vs. 44.1 %) | ||
| Cash Gifts | Yoo et al., (2022) | 1000 low-income mothers with infants | Cash transfers to low-income mothers to influence substance use | n.s., differences in maternal substance use. n.s., opioid use effect size: −0.067 ( |
|
| Basic needs | Gryczynski et al., (2021) | 400 patients with co-occurring SUDs | Patient navigators in hospitals featuring links to basic needs | Faster entry into treatment ↑ SUD treatment entry within 3 months (50.3 % intervention vs 35.3 % TAU) Faster entry into treatment ↑ MOUD treatment entry within 3 months (68 % intervention vs 40 % TAU) ↓ positive opioid drug test within 6 months (68 % vs 74 % TAU) |
|
| Dahlem et al., (2021) | 122 patients who experienced non-fatal overdose | Community case management navigators and peer coaches featuring linkages to basic needs | 33.6 % received ongoing treatment services | ||
| Tuten et al., (2018) | 135 individuals with OUD | Psychosocial treatment featuring linkages to basic needs | ↑abstinence at 6-months (slope: −0.56) | ||
| Neighborhood and physical environment | Housing | Crowthers et al., (2022) | 117 PWOUD | Peer recovery coaching | ↑ rate of abstinence (X2=20.0) ↑ housing stability (X2=7.14) |
| Dahlem et al., (2021) | 122 patients who experienced non-fatal overdose | Community case management navigators and peer coaches featuring linkages to housing | 33.6 % received ongoing treatment services | ||
| Davidson et al., (2014) | 358 PWOUD | Consumer-participation for people with homelessness and substance use | ↓ likely to report using stimulants or opiates at follow-up (OR: 0.17) | ||
| Kelleher et al., (2021) | 21 people at risk for OUD | Housing first intervention, providing six months of rent, utilities, and OUD prevention services | No participants reported opioid use by the 6-month follow-up | ||
| Ly et al., (2024) | 38 PWOUD | Pharmacist-led buprenorphine outreach services at Permanent Supportive Housing for people with OUD. | ↑ treatment adherence among intervention groups (37 % vs. 3 % achieved 80 % of prescription days filled) | ||
| Tuten et al., (2018) | 135 PWOUD | Access to recovery housing during treatment | ↑ opioid abstinence at 1, 3, and 6 months (β: −1.07, 1.46, 1.40) in the housed group. Employment ↑ abstinence at 3- and 6-months (β: 1.20, 1.19) |
3.2.1. Provider knowledge and practice
Whiteside and colleagues (2021) piloted an intervention that included case management, bedside linkages to care, overdose medications, and provider-level OUD education. While this intervention focused on access to care through case management and linkages, it also involved a clinical care component (overdose medication, naloxone). The number of days of illicit opioid use decreased at the 1-month and 3-month follow-up time points for both groups (Mean = 12 vs. 9 days). At 3 months, intervention participants reported 3.5 fewer days of heroin use compared to participants in TAU, although this difference was not statistically significant (Whiteside et al., 2021). McCarthy et al., (2019) sent reminders to ED-based providers to counsel patients about safe usage of opioid medications to prevent opioid misuse. This study produced mixed results: the survey data indicated consultation increased the likelihood of safe opioid use compared to patients in TAU (aOR 2.46, CI 1.19, 5.06) but not when examining returned opioid use diaries.
Two studies included interventions to promote adherence to opioid prescribing guidelines. Quanbeck et al. (2018) conducted a randomized controlled trial with a matched-pair design to implement a systems consultation strategy in eight community-based primary care clinics. This strategy included audit and feedback, academic detailing (face-to-face education), and external facilitation (process management support) to enhance adherence to opioid prescribing guidelines. The authors found intervention group reductions from pre- to post-test in the proportion of patients with three or more opioid prescriptions in the past 3months (but not when compared to TAU (slope: 0.0001, CI: − 0.0001, − 0.0002) but no significant differences compared to TAU (Quanbeck et al., 2018). Another RCT study successfully improved the quality of care by reducing over-prescribing of prescription opioids to prevent misuse (Deshazer et al., 2020).
3.2.2. Stigma in healthcare settings
Howard and Clark (2017) developed a provider training intervention using the Interpersonal Shared Decision-Making model aimed to reduce provider bias against pregnant women who use substances through a training intervention that covered gaps in treatment options, child welfare laws, universal verbal screening, and community resources. They reported a 73 % decrease in the proportion of providers agreeing that “women with substance use problems should not parent” (Howard and Clark, 2017). Hershberger and colleagues’ (2022) randomized study tested an online virtual reality simulation of a healthcare encounter to reduce stigma among health professionals. The simulation included immersive scenarios featuring a pregnant woman with OUD and evidence-based habit-breaking strategies such as perspective taking and individuation to reduce prejudice. Although the mean difference in overall bias scores pre-test/post-test was not significant for pregnant women using opioids, providers showed significant improvements in reduced frustration and increased compassion (mean differences of −.45 and −.31, p < .05) (Hershberger et al., 2022).
3.2.3. Quality of care and access
Molfenter et al. (2019) implemented a multi-organizational learning collaborative to reduce reimbursement and access barriers to MOUD as buprenorphine (BUP). This intervention incorporated Network for the Improvement of Addiction Treatment (NIATx) learning sessions and coaching for payers and treatment agencies to make organizational changes facilitated by implementation teams comprised of representatives from Ohio’s Alcohol, Drug Addiction, and Mental Health Service board and treatment agency staff. The teams addressed workforce, operational, and access-related barriers. For example, to address operational barriers to identify and support patients eligible for BUP, NIATx learning sessions and coaching were used to develop standardized screening workflows, implement diversion prevention protocols, and connect patients to support groups accepting MOUD. As another example, the intervention supported prescriber capacity by recruiting waivered clinicians, encouraging waiver applications among existing staff, and maximizing the use of available prescriber slots. The intervention led to a three-fold increase in BUP use among OUD patients (from 9.5 % to 28.5 %), compared to a smaller increase in the comparison group (from 10.9 % to 19.6 %), with an adjusted difference-in-differences of 10 % (95 % CI [9.9 %, 10.7 %], p < .001). Hagedorn and colleagues (2022) used block randomization to implement quality improvement interventions in eight Veterans Health Administration facilities. The intervention tested an implementation team to increase MOUD provision. The intervention assessed local barriers and facilitators, formed local implementation teams and action plans for training/education, and provided ongoing coaching and consultation. The proportion of patients with OUD receiving MOUD increased from an average of 18 % at baseline to 30 % one year later.
Ly and colleagues (2024) evaluated the impact of an innovative pharmacist-led pilot service in providing access to BUP treatment to individuals residing in Permanent Supportive Housing and receiving support for their wellness, quality of life, and housing retention. The intervention improved treatment adherence among intervention participants; 37 % post- vs. 3 % pre-intervention participants achieved 80 % of prescription days filled. (Ly et al., 2024).
Gryczynski et al. (2021) conducted an RCT of patient navigators (NavSTAR) provided case management, advocacy, service linkage, and motivational support to address medical and basic needs (housing, food, clothing, etc.). NavSTAR patients had higher rates of medication for OUD (MOUD) treatment entry within 3, 6 and 12 months (68 % vs 40 %; 83 % vs 49 %; 87 vs 67 %) and lower rates of positive opioid drug test within 6 months (68 % vs 74 %) compared to TAU. Conversely, to improve quality care, Suzuki et al. (2023) conducted an RCT of a peer recovery coach intervention with hospitalized patients with OUD, involving provision of a relapse prevention plan, contact for six months post-discharge, encouragement of medication for MOUD adherence, and identifying linkages to recovery resources. However, there were no significant differences between the TAU group’s and the intervention group’s retention on MOUD (38.5 % vs 41.7 %), hospital readmissions (46.2 % vs 41.2 %), or time to treatment discontinuation (logrank p = 0.92) and readmission (logrank p = 0.85) (Suzuki et al., 2023).
3.3. Community and social context
Thirteen (30 %) of the 27 SDOH studies targeted community and social context. Interventions included social integration via peer social supports, utilization of community coalitions to coordinate community-wide changes, or parenting skills to improve the family social context. Three studies (23 %) within this domain included randomization. See Tables 3 and 4.
3.3.1. Peer social support and recovery
Hyde and colleagues (2022) piloted a post-incarceration peer-based intervention to promote engagement in social support, substance use, and mental health services among veterans. Peers offered socioemotional support, referrals, role modeling of life skills, and they attended participants’ medical appointments. The intervention was associated with higher linkage and engagement in substance use services (86 % vs. 19 %) and other specialized care for veterans returning to the community after incarceration, suggesting better social integration than the comparison group (Hyde et al., 2022). Crowthers and colleagues (2022) examined a peer recovery coaching intervention that addressed relationships and social support and social determinants like economic stability (e.g., financial independence and employment), education, and independence from legal challenges and institutions. Participants showed higher abstinence rates (X2=20.0), but modest non-significant (p > .05) increases in social connectedness (i.e., from 90 % to 98 %; X2=2.67).
3.3.2. Community context and coalitions
Community coalitions can be a coordinated approach to reduce risk factors at the community-level and influence local attitudes (Alexandridis et al., 2019). Alexandridis and colleagues (2019) implemented community-coalition interventions across 74 counties in North Carolina. Coalition efforts included community and school-based education and mass media campaigns to increase community awareness about prescription drug overdose prevention, as well as diversion control efforts (e.g., disposing of unused medications and educating law enforcement about opioid analgesics), and changing local policies to distribute naloxone to OUD-affected families, friends, and first responders. In addition to community context, intervention components overlapped with the SDOH healthcare domain (community-wide provider education, hospital ED policy changes, and MOUD treatment expansion). Interestingly, the diversion control component was linked to increased opioid analgesic dispensing (IRR: 1.06), and other strategies did not reduce prescribing (p > .05). Community-wide treatment expansion had no association with changes in BUP utilization (IRR: 0.98) (Alexandridis et al., 2019). Additionally, a grassroots coalition held forums that increased awareness of opioid-involved overdose and resulted in community-level goals to address the OUD crisis (e.g., creation of a local coalition to focus on addressing and prevention of substance use) (Palombi et al., 2019). The Communities That HEAL (CTH) intervention, a multi-site, community-level, cluster-randomized waitlist-controlled trial, seeks to reduce opioid overdose deaths through evidence-based practices, community engagement, and health communication campaigns in 67 highly impacted communities (Davis et al., 2024; Glasgow et al., 2024). Wave 1 results show a 25 % increase in access to therapies for OUD compared to wait-list controls (Glasgow et al., 2024) and a larger decrease in perceived community stigma toward people treated for OUD (AMC −3.20) and MOUD (AMC −0.33) than in wait-list controlled communities (AMC −0.18 and AMC 0.11) (Davis et al., 2024).
3.3.3. Family context
Family interactions fall within the SDOH domain of community and social context and can significantly impact an individual’s health. Godwin and colleagues found lower probability of opioid use later in life among participants who received a comprehensive childhood intervention that targeted, among other needs, parents’ parenting skills and behaviors (Godwin and Conduct Problems Prevention Research Group, 2020). Schaeffer and colleagues (2021) conducted an RCT of a family intervention to improve parenting skills, reduce physical interpersonal violence, substance misuse, and child maltreatment, and to improve the overall family context. Parents showed a significant decrease in days of opioid use over time (β: −0.34, p < .05) and were more likely to report total past-month abstinence from all drugs (β: −0.06), but the difference was only marginally significant for past-month opioid abstinence (β: −1.45; p = 0.055) (Schaeffer et al., 2021).
3.4. Economic stability
Interventions within the economic stability domain (n = 7; 16 %) included employment-based reinforcements, employment services via peer navigators and coaches, or financial incentives to bolster economic stability. Over half of the studies in this domain used a randomized design (57 %). See Tables 3, 4 and 5.
3.4.1. Employment services and wage supports
Holtyn and colleagues (2014) assessed whether a therapeutic workplace that offers an employment-based incentive program (contingency-management-based therapeutic workplace) could foster enrollment in methadone treatment and drug abstinence among out-of-treatment patients who inject drugs. Most participants were engaged in methadone treatment during the induction phase (92 %). The therapeutic workplace was a research-based model whereby participants were hired and paid contingent on specific behaviors. For example, training programs helped build skills and were structured to simulate employment while reinforcing treatment engagement and abstinence. In the most intensive intervention condition (compared to work only, or work plus methadone treatment), participants were required to enroll in methadone treatment, attend the workplace, and provide drug-free urine samples to maximize earnings. This intervention resulted in higher percentage of opioid-free urine samples compared to the work-only intervention (75 % vs. 54 %) (Holtyn et al., 2014).
Novak and colleagues (2022) investigated long-term abstinence-contingent wage supplements to promote drug abstinence and employment among unemployed adults enrolled in an opioid agonist treatment program (compared to Treatment as Usual, TAU). All participants were offered an employment specialist throughout the 12-month intervention period. Participants in the intervention group received stipends for engaging in job-seeking activities and, once employed, wage supplements for hours worked in community jobs, contingent on providing drug-free urine samples. Participants in the intervention group provided a higher rate of opioid- and cocaine-free urine samples than TAU participants (44.1 % vs. 3.6 %) (Novak et al., 2022). As noted earlier, Crowthers and colleagues (2022) included “education services” in their peer recovery coaching study. The authors noted that this intervention included “education and employment services.” Because outcomes were “exclusively related to employment” (i.e., no participants reported education activities at baseline or follow-up), however, we have classified this intervention under the employment domain. Peer recovery was associated with increased rates of being employed (X2=19.17, p < 0.001) and, as mentioned above, a higher rate of abstinence (X2=20.0) at the 6-month follow-up compared to baseline.
3.4.2. Financial assistance
Yoo and colleagues (2022) conducted an RCT of low-income mothers with infants to examine if unconditional cash gifts of significant monthly value ($333) versus a nominal value ($20) would influence maternal use of alcohol, cigarettes, or opioids. No differences were found in maternal substance use. The effect size estimate for change in opioid use was negative (−0.067) and not statistically significant, suggesting that providing cash gifts to low-income mothers with infants did not increase their opioid use (Yoo et al., 2022).
3.5. Neighborhood and physical environment
Fewer interventions targeted the neighborhood or physical environment (n = 4; 9 %), and they were all limited to housing interventions. Interventions included efforts to increase access to affordable housing for those at risk of developing OUD or in recovery from OUD. These interventions were often embedded within more holistic interventions. None included randomization. See Tables 3, 4 and 5.
3.5.1. Housing
Stable and affordable housing can lower the risk of substance use (Substance Abuse and Mental Health Services Administration, 2023a, 2023b). Several articles included Housing First interventions, which provide immediate, permanent housing to individuals experiencing homelessness, coupled with supportive services to address their health and social needs without preconditions such as substance abstinence. Overlapping with the economic stability domain, Kelleher and colleagues (2021) used a Housing-First intervention providing six months of rent, utilities, and OUD prevention services. The intervention covered a housing deposit, application fees (including rental history and credit report), and automatic monthly payments for rent and utilities for 6 months. Despite the high risk of OUD among young adults (over 18 years old) experiencing homelessness, no participants reported opioid use by the 6-month follow-up (Kelleher et al., 2021). Tuten and colleagues (2018) found that participants who accessed recovery housing (i.e., communal, supportive, and supervised substance-free living environments for people recovering from SUDs) during treatment were more likely to be opioid abstinent at 1, 3 and 6 months (β: −1.07, 1.46, 1.40, respectively). Housing First strategies were identified as feasible and effective in reducing opioid use (Davidson et al., 2014; Kelleher et al., 2021). Davidson and colleagues (2014) examined the active participation of people experiencing homelessness, whose substance use hindered independent housing, in the design and implementation of Housing First. Providers used a Housing First approach for providing client-centered supportive services to improve retention. Clients in programs that included Housing First participants in decision-making were less likely than others to report using stimulants or opioids at follow-up (OR: 0.17). Crowthers and colleagues (2022) used peer recovery coaching, which included the housing services and other supports discussed earlier. The authors found increased rates of housing stability (X2=7.14, p = 0.008) and, as previously mentioned, a higher rate of abstinence (X2=20.0) at the 6-month follow-up (compared to baseline).
3.6. Education
Only one of 27 SDOH studies intervened in early education, and it used an RCT to assess intervention effects on opioid use in adulthood (Godwin et al., 2020). See Tables 3, 4 and 5.
3.6.1. Early education
In a randomized pre-test/post-test design to reduce aggression and delinquency in at-risk kindergarteners, Godwin and colleagues (2020) intervened on social and emotional development in early education. They used a comprehensive childhood intervention that targeted academic skills, children’s intrapersonal and interpersonal skills, and parenting skills and behaviors through two intervention phases: elementary (grades 1–5) and secondary (grades 6–10) school. By young adulthood (ages 19–25), intervention participants reported lower weekly use of opioids in the past 12 months compared to control participants (1.7 % vs 4.1 %). The intervention was associated with a 61 % reduction in the likelihood of opioid use.
4. Discussion
Interventions targeting SDOH to improve OUD outcomes remain limited. This review identified 27 studies that sufficiently met criteria for SDOH-focused interventions and opioid use; this small number of eligible studies highlight the need for additional research in this area. Our review adopted a broad definition of SDOH interventions, recognizing that SDOH interventions may operates at multiple levels – from structural- and community-level interventions to individual-level efforts that address the consequences of social inequities. This inclusive approach allowed us to capture the current landscape of SDOH interventions but also revealed a critical gap: There is a scarcity of upstream interventions targeting the root causes of SDOH-related variations in terms of access to healthcare, OUD treatment, and supportive recovery services. Given that SDOH are known to influence the development, persistence, and outcomes of OUD and drive disparities in OUD outcomes (Lin et al., 2024), our findings substantiate areas that represent missed opportunities to intercede to curtail OUD and reduce health impacts and social consequences. Expanding interventions across multiple SDOH domains, as several included studies attempted to some degree, appears to be a viable approach to reduce disparities and improve OUD outcomes, including among individuals with SDOH factors that limit their access to needed services. Targeted interventions can improve health outcomes and achieve long-term societal savings (Thornton et al., 2016).
This scoping review revealed several key gaps in this area of research. Among the reviewed articles, there was a lack of breadth within each SDOH domain. Most (52 %) focused on the healthcare domain, aiming to improve provider knowledge, practice, and quality, leading to reduced opioid use (Alexandridis et al., 2019; Deshazer et al., 2020; Hershberger et al., 2022; Howard and Clark, 2017), or improved treatment initiation (Crowthers et al., 2022; Gryczynski et al., 2021; Hyde et al., 2022; Whiteside et al., 2021). Few studies addressed other factors, like OUD stigma among providers (Hershberger et al., 2022; Howard and Clark, 2017), linguistic and cultural competency, or insurance coverage, indicating missed opportunities (National Quality Forum, 2022). In the neighborhood and environment domain, most interventions relied on Housing First components to reduce opioid use (Crowthers et al., 2022; Dahlem et al., 2021; Davidson et al., 2014; Kelleher et al., 2021; Ly et al., 2024; Tuten et al., 2018), but none addressed other factors like the built environment outside of participants’ own housing or neighborhood safety. Articles addressing the domains of neighborhood and economic stability often focused on recovery navigator interventions linking individuals to housing or employment support, which was associated with reduced opioid use (Crowthers et al., 2022; Holtyn et al., 2014; Novak et al., 2022). Notably, Kelleher et al. (2021) provided rental assistance (neighborhood and environment domain) and did not find any opioid use among at-risk participants within six months of the project, while Yoo et al. (2022) offered cash provisions (economic stability domain), which did not increase use.
Community-wide interventions influenced social supports and contexts, which were associated with increased abstinence (Alexandridis et al., 2019; Crowthers et al., 2022; Dahlem et al., 2021), while family-context interventions reduced opioid use (Godwin et al., 2020; Schaeffer et al., 2021). Notably, recent studies have used coalitions or mass media campaigns to increase awareness of OUD (Palombi et al., 2019), decrease stigma of people with OUD (Davis et al., 2024), and improve access to OUD treatment (Alexandridis et al., 2019; Glasgow et al., 2024). Given the evidence linking social cohesion and community support to reduced OUD, there may be additional opportunities for interventions that address community-level factors like stress, social cohesion, or civic participation (Avery et al., 2021; Dasgupta et al., 2018; Hser, 2007; Warren et al., 2007). Interventions in the education domain were understudied, with one focusing on elementary and secondary education to prevent opioid use in adulthood (Godwin et al., 2020), and no interventions addressing other education factors, such as high school graduation rates or education quality, highlighting a gap in OUD prevention strategies (Braveman, 2023; Lin, 2024). Overall, the limited focus on broader SDOH factors such as neighborhood, community, economic, and educational factors combined with the interrelated and interacting nature of these domains, underscoring the need for comprehensive, multi-faceted interventions to effectively address the spectrum of SDOH influence on OUD (ODPHP, 2024).
SDOH interventions were implemented in a limited number of settings but spanned the United States. Multiple studies were conducted in Massachusetts, New York, North Carolina, Maryland, and Ohio, representing both urban (e.g., Baltimore) and rural areas (e.g., rural northeast Minnesota). However, most interventions were conducted in healthcare settings (e.g., hospitals or SUD treatment centers), and fewer were conducted within community settings despite the importance of SDOH interventions designed with input from people from the surrounding community. Community settings play a critical role in addressing the broader social and environmental factors influencing OUD outcomes. Interventions that are conducted in community settings, that address the community and social context, and that include community members (e. g., people with lived or living experience) can empower local communities to develop tailored solutions for reducing OUD risk and improving OUD outcomes (Bermea et al., 2019; Collins et al., 2019; Feld et al., 2023; Palombi et al., 2019; Rhodes et al., 2005; Singer, 2000). This empowerment is exemplified in the study by Palombi and colleagues, which showed a promising first step toward community-identified solutions (2019).
SDOH interventions have methodological and design issues that make it challenging to evaluate their effectiveness. Firstly, inconsistent terminology limits SDOH intervention evaluations. Equating SDOH to individual-level social risk factors further complicates the ability to effectively evaluate SDOH interventions that operate at structural and system levels (Alderwick and Gottlieb, 2019; Braveman and Gottlieb, 2014). Secondly, evaluating impacts of SDOH interventions has been limited by variations in study design. Over a third of studies used one-group quasi-experimental designs. These designs can be useful when randomization is not feasible, but they have limited protection against threats to internal validity and are more susceptible to biases. Although more than half of the articles on SDOH interventions included RCTs, which are considered the gold standard for establishing effectiveness, many studies focused on feasibility and acceptability rather than more meaningful efficacy outcomes (Dahlem et al., 2021; Smith et al., 2022). Utilizing RCTs may be challenging for upstream SDOH interventions due to the complexity of causal pathways, the long periods required to observe outcomes, variability in population responses, ethical dilemmas around randomization, and a perceived lack of methodological alternatives, all of which can limit the assessment of upstream intervention effects (Braveman, 2023). Moreover, many SDOH interventions incorporate several components to address multiple SDOH domains or social needs. For example, studies utilized peer navigators to connect patients to a variety of social services, including finding and maintaining employment or making social connections (Crowthers et al., 2022; Dahlem et al., 2021; Gryczynski et al., 2021; Tuten et al., 2018). Other interventions addressed multiple social needs such as housing, social support, education, or transportation provisions as part of service navigation or disease management strategies (Gryczynski et al., 2021; Whiteside et al., 2021), while housing supports were often embedded within holistic interventions (Crowthers et al., 2022; Dahlem et al., 2021), making it difficult to isolate the impact of specific intervention components. To address these challenges, researchers should adopt standardized definitions and frameworks for SDOH that include both individual and structural factors (Andermann, 2018) and clearly distinguish between social needs, which are often direct impacts of SDOH, and structural-level SDOH, which encompass the broader contextual factors influencing health outcomes (Castrucci, Auerbach, n.d.). Effective measurement strategies could include standardized tools capturing downstream SDOH contexts or social needs, such as housing stability, income, education, and healthcare access (Khurana et al., 2022). Future research should prioritize the development and validation of comprehensive, multi-component evaluation frameworks that can assess the complex and multifaceted nature of SDOH interventions, as well as the complexities of the SDOH domains they intend to address.
This review is among the first to evaluate SDOH interventions for their ability to improve OUD outcomes in the U.S. We conducted a comprehensive review of the current literature using multiple search strategies and two independent reviewers to minimize bias, with a pre-established review protocol for transparency. Despite these strengths, the study has limitations. First, the search was limited to articles published within an 11-year period in the U.S. (from 2013 to 2024). For example, this review may have missed SDOH-informed prevention strategies because they were published prior to our inclusion window or did not include the word “opioid” within the abstract. Future research should include a focused scoping review of SDOH-informed prevention strategies aimed at reducing later opioid use. Such a review may reveal additional family-oriented or school-based interventions (Spoth et al., 2008). Second, there is no standardized MeSH term for SDOH, which may lead to missing papers. Third, the study design criteria for inclusion may have resulted in fewer identified SDOH interventions, but it ensured that only studies assessing intervention effects were included. Fourth, although we conducted a hand search of Google Scholar to capture gray literature, this review did not identify any gray literature. Finally, some studies were excluded because they were SDOH-adjacent or did not meet study design requirements (e.g., comparison group or time point). For example, we excluded studies focusing on patient health literacy, knowledge, and problem-solving (Braveman, 2023). We defined education as education attainment and therefore excluded interventions that educated patients about OUD or OUD treatments (H. E. Jones et al., 2021; J. D. Jones et al., 2022; Kelleher et al., 2021; LaSane et al., 2022; Lott and Rhodes, 2016; McElhinny et al., 2021; Morasco et al., 2022). However, some studies that were excluded due to specific design issues that impacted reporting of their results still deserve mention. For instance, The Safe Passages program allowed people with OUD to enter the police department to seek treatment without fear of arrest (social and community context domains), but relied on qualitative methods (Jurgens et al., 2024). The MAT-PLUS intervention created a supportive family context to improve adherence with MOUD as long-acting injectable naltrexone (social and community context domains) but the article did not report OUD results separately (Wenzel et al., 2021), nor did the START study (Ober et al., 2023), which provided addiction consultation and support services to hospitalized patients, aiming to enhance healthcare quality (healthcare domain). Despite these limitations, this review provides valuable insights into SDOH interventions to improve OUD outcomes and highlights areas of opportunity needing additional research. Finally, while our review focused on interventions addressing SDOH domains, manystudies useddownstream and midstream interventions.
5. Conclusions
There is a pressing need to understand the potential impact of SDOH interventions on OUD outcomes. The majority of SDOH interventions we identified were focused on individual-level approaches to mitigate the effects of structural inequities. This reflects a broader trend in the field and underscores the need for more upstream interventions. Thus, our findings underscore public health calls for interventions to address root causes (Frieden, 2010). Policies to improve population-level wages, enhance healthcare systems, and provide economic support and educational opportunities may have the most significant impact on population-level health, yet are challenging to implement (Frieden, 2010). SDOH interventions, including cash assistance, vocational training, support for education attainment, social reentry programs, and supportive social and physical environments, may mitigate factors associated with OUD and may be easier to design and implement than population-level interventions. Public health interventions that integrate both upstream and downstream strategies are essential to improving the lives of people with OUD. To maximize the effectiveness of these strategies, however, it is essential to resolve measurement issues to best understand the impacts of these approaches. Harmonizing SDOH terms and metrics across studies, along with developing standardized measurement tools and outcome measures specific to SDOH domains, is crucial for advancing research and comparing study results.
Supplementary Material
Funding
The efforts of the authors were supported by the National Institute of Health - National Institute on Drug Abuse UG1DA049435.
Footnotes
CRediT authorship contribution statement
Fei Wu: Writing – review & editing, Funding acquisition. Yih-Ing Hser: Writing – review & editing, Supervision, Resources, Project administration, Funding acquisition, Conceptualization. Larissa J. Mooney: Writing – review & editing, Supervision. Layla Tondravi: Writing – review & editing, Validation. Clingan Sarah E: Writing – original draft, Formal analysis, Data curation. Chunqing Lin: Writing – review & editing, Writing – original draft, Supervision, Methodology, Formal analysis, Data curation, Validation, Conceptualization. Yuhui Zhu: Writing – review & editing, Writing – original draft, Formal analysis, Data curation. Sarah J. Cousins: Writing – review & editing, Writing – original draft, Validation, Supervision, Project administration, Methodology, Formal analysis, Data curation, Conceptualization.
Declaration of Competing Interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
REFERENCES
- Abraham AJ, Knudsen HK, Rieckmann T, Roman PM, 2013. Disparities in access to physicians and medications for the treatment of substance use disorders between publicly and privately funded treatment programs in the United States. J. Stud. Alcohol Drugs 74 (2), 258–265. 10.15288/JSAD.2013.74.258. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Abraham AJ, Andrews CM, Harris SJ, Friedmann PD, 2020. Availability of medications for the treatment of alcohol and opioid use disorder in the USA. Neurotherapeutics 17 (1), 55–69. 10.1007/s13311-019-00814-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Alderwick H, Gottlieb LM, 2019. Meanings and misunderstandings: a social determinants of health lexicon for health care systems. Milbank Q. 〈https://www.milbank.org/quarterly/articles/meanings-and-misunderstandings-a-social-determinants-of-health-lexicon-for-health-care-systems/〉. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Alexandridis AA, Dasgupta N, McCort AD, Ringwalt CL, Rosamond WD, Chelminski PR, Marshall SW, 2019. Associations between implementation of project lazarus and opioid analgesic dispensing and buprenorphine utilization in north carolina, 2009–2014. Inj. Epidemiol 6 (1). 10.1186/s40621-018-0179-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Altekruse SF, Cosgrove CM, Altekruse WC, Jenkins RA, Blanco C, 2020. Socioeconomic risk factors for fatal opioid overdoses in the United States: findings from the mortality disparities in American communities study (MDAC). PLOS ONE 15 (1), e0227966. 10.1371/journal.pone.0227966. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Andermann A, 2018. Screening for social determinants of health in clinical care: moving from the margins to the mainstream. Public Health Rev 39, 19. 10.1186/s40985-018-0094-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Avery EE, Hermsen JM, Kuhl DC, 2021. Toward a better understanding of perceptions of neighborhood social cohesion in rural and urban places. Soc. Indic. Res 157, 523–541. [Google Scholar]
- Bermea AM, Lardier DTJ, Forenza B, Garcia-Reid P, Reid RJ, 2019. Communitarianism and youth empowerment: motivation for participation in a community-based substance abuse prevention coalition. J. Community Psychol 47 (1), 49–62. 10.1002/jcop.22098. [DOI] [PubMed] [Google Scholar]
- Bond Edmond M, Aletraris L, Roman PM, 2015. Rural substance use treatment centers in the United States: an assessment of treatment quality by location. Am. J. Drug Alcohol Abus 41 (5), 449–457. 10.3109/00952990.2015.1059842. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Braveman P, 2023. The social determinants of health and health disparities. Oxford University Press. 10.1093/oso/9780190624118.001.0001. [DOI] [Google Scholar]
- Braveman P, Gottlieb L, 2014. The social determinants of health: It’s time to consider the causes of the causes. Public Health Rep 129 (2(, 2), 19–31. 10.1177/00333549141291S206. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Castrucci BC, & Auerbach J (n.d.). Meeting Individual Social Needs Falls Short Of Addressing Social Determinants Of Health. Retrieved September 19, 2024, from 〈https://www.healthaffairs.org/do/10.1377/forefront.20190115.234942/full/〉
- Chang JE, Franz B, Cronin CE, Lindenfeld Z, Lai AY, Pagán JA, 2022. Racial/ethnic disparities in the availability of hospital based opioid use disorder treatment. J. Subst. Abus. Treat 138, 108719. 10.1016/j.jsat.2022.108719. [DOI] [PubMed] [Google Scholar]
- Cockerham WC, Hamby BW, Oates GR, 2017. The social determinants of chronic disease. Am. J. Prev. Med 52 (1), 5–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Collins AB, Boyd J, Mayer S, Fowler A, Kennedy MC, Bluthenthal RN, Kerr T, McNeil R, 2019. Policing space in the overdose crisis: a rapid ethnographic study of the impact of law enforcement practices on the effectiveness of overdose prevention sites. Int. J. Drug Policy 73, 199–207. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Crowthers RA, Arya M, Venkataraman A, Lister JJ, Cooper SE, Enich M, Stevens S, Bender E, Sanders R, Stagliano K, Jermyn RT, 2022. Impact of an osteopathic peer recovery coaching model on treatment outcomes in high-risk men entering residential treatment for substance use disorders. J. Osteopath. Med 122 (10), 521–529. 10.1515/jom-2022-0066. [DOI] [PubMed] [Google Scholar]
- Dahlem C.H. (Gina), Scalera M, Anderson G, Tasker M, Ploutz-Snyder R, McCabe SE, Boyd CJ, 2021. Recovery opioid overdose team (ROOT) pilot program evaluation: a community-wide post-overdose response strategy. SUBSTANCE ABUSE 42 (4), 423–427. 10.1080/08897077.2020.1847239. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dasgupta N, Beletsky L, Ciccarone D, 2018. Opioid crisis: no easy fix to its social and economic determinants. Am. J. Public Health 108 (2), 182–186. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Davidson C, Neighbors C, Hall G, Hogue A, Cho R, Kutner B, Morgenstern J, 2014. Association of housing first implementation and key outcomes among homeless persons with problematic substance use. Psychiatr. Serv 65 (11), 1318–1324. 10.1176/appi.ps.201300195. [DOI] [PubMed] [Google Scholar]
- Davis A, Knudsen HK, Walker DM, Chassler D, Lunze K, Westgate PM, Oga E, Rodriguez S, Tan S, Holloway J, Walsh SL, Oser CB, Lefebvre RC, Fanucchi LC, Glasgow L, McAlearney AS, Surratt HL, Konstan MW, Huang TT-K, Huerta TR, 2024. Effects of the communities that heal (CTH) intervention on perceived opioid-related community stigma in the HEALing communities study: results of a multi-site, community-level, cluster-randomized trial. Lancet Reg. Health Am 32. 10.1016/j.lana.2024.100710. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Deshazer C, Dominic O, Deleo C, Johnson R, 2020. Impact of a health system’s three-pronged strategy to address the opioid epidemic in de, pa, and wv, 2013–2017. Open Public Health J 13 (1), 152–160. 10.2174/1874944502013010152. [DOI] [Google Scholar]
- van Draanen J, Tsang C, Mitra S, Karamouzian M, Richardson L, 2020. Socioeconomic marginalization and opioid-related overdose: a systematic review. Drug Alcohol Depend 214, 108127. 10.1016/j.drugalcdep.2020.108127. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Feld H, Elswick A, Goodin A, Fallin-Bennett A, 2023. Partnering with recovery community centers to build recovery capital by improving access to reproductive health. J. Nurs. Scholarsh. Off. Publ. Sigma Theta Tau Int. Honor Soc. Nurs 55 (3), 692–700. 10.1111/jnu.12836. [DOI] [PubMed] [Google Scholar]
- Formosa EA, Kishimoto V, Orchanian-Cheff A, Hayman KG, 2019. 302 emergency department interventions for homelessness: a systematic review. Ann. Emerg. Med 74 (4), 119. [DOI] [PubMed] [Google Scholar]
- Frieden TR, 2010. A framework for public health action: the health impact pyramid. Am. J. Public Health 100 (4), 590–595. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Glasgow L, Douglas C, Sprunger JG, Campbell ANC, Chandler R, Dasgupta A, Holloway J, Marks KR, Roberts SM, Martinez LS, Thompson K, Weiss RD, Aldridge A, Asman K, Barbosa C, Blevins D, Chassler D, Cogan L, Fanucchi L, El-Bassel N, 2024. Effect of the communities that HEAL intervention on receipt of behavioral therapies for opioid use disorder: a cluster randomized wait-list controlled trial. Drug Alcohol Depend 259, 111286. 10.1016/j.drugalcdep.2024.111286. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Godwin JW, Conduct Problems Prevention Research Group, 2020. The fast track intervention’s impact on behaviors of despair in adolescence and young adulthood. Proc. Natl. Acad. Sci. USA 117 (50), 31748–31753. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gryczynski J, Nordeck CD, Welsh C, Mitchell SG, O’Grady KE, Schwartz RP, 2021. Preventing hospital readmission for patients with comorbid substance use disorder: a randomized trial. Ann. Intern Med 174 (7), 899–909. [DOI] [PubMed] [Google Scholar]
- Hagedorn HJ, Gustavson AM, Ackland PE, Bangerter A, Bounthavong M, Clothier B, Harris AHS, Kenny ME, Noorbaloochi S, Salameh HA, Gordon AJ, 2022. Advancing pharmacological treatments for opioid use disorder (ADaPT-OUD): an implementation trial in eight veterans health administration facilities. J. Gen. Intern Med 37 (14), 3594–3602. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Han BH, Doran KM, Krawczyk N, 2022. National trends in substance use treatment admissions for opioid use disorder among adults experiencing homelessness. J. Subst. Abus. Treat 132, 108504. 10.1016/j.jsat.2021.108504. [DOI] [PubMed] [Google Scholar]
- Hansen H, Jordan A, Plough A, Alegria M, Cunningham C, Ostrovsky A, 2022. Lessons for the opioid Crisis-Integrating social determinants of health into clinical care. Am. J. Public Health 112 (S2). 10.2105/AJPH.2021.306651. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hershberger PJ, Pei Y, Crawford TN, Neeley SM, Wischgoll T, Patel DB, Vasoya MM, Castle A, Mishra S, Surapaneni L, Pogaku AA, Bositty A, Pavlack T, 2022. An interactive game with virtual reality immersion to improve cultural sensitivity in health care. HEALTH EQUITY 6 (1), 189–197. 10.1089/heq.2021.0128. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Holtyn AF, Koffarnus MN, DeFulio A, Sigurdsson SO, Strain EC, Schwartz RP, Leoutsakos J-MS, Silverman K, 2014. The therapeutic workplace to promote treatment engagement and drug abstinence in out-of-treatment injection drug users: a randomized controlled trial. Prev. Med 68, 62–70. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Howard H, Clark K, 2017. Interprofessional-shared decision making for pregnant women with opioid use: results from a provider training. Curr. Women’S. Health Rev 13 (2), 121–129. 10.2174/1573404813666170511115024. [DOI] [Google Scholar]
- Hser Y-I, 2007. Predicting long-term stable recovery from heroin addiction: findings from a 33-year follow-up study. J. Addict. Dis 26 (1), 51–60. [DOI] [PubMed] [Google Scholar]
- Hser Y-I, Evans E, Grella C, Ling W, Anglin D, 2015. Long-term course of opioid addiction. Harv. Rev. Psychiatry 23 (2), 76–89. 10.1097/HRP.0000000000000052. [DOI] [PubMed] [Google Scholar]
- Hyde J, Byrne T, Petrakis BA, Yakovchenko V, Kim B, Fincke G, Bolton R, Visher C, Blue-Howells J, Drainoni M-L, Mclnnes DK, 2022. Enhancing community integration after incarceration: findings from a prospective study of an intensive peer support intervention for veterans with an historical comparison group. HEALTH JUSTICE 10 (1). 10.1186/s40352-022-00195-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jin C, Nwangwu-Ike N, Gant Z, Johnson Lyons S, Satcher Johnson A, 2017. Geographic differences and social determinants of health among people with HIV attributed to injection drug use. U. S. 2022 137 (3), 525–536. 10.1177/00333549211007168. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jones HE, Martin CE, Andringa KR, Ellerson RM, Johnson E, Hairston E, Grady KEO, 2021. Sex and female empowerment (SAFE): a randomized trial comparing sexual health interventions for women in treatment for opioid use disorder. Drug Alcohol Depend 221, 108634. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jones JD, Campbell AN, Brandt L, Metz VE, Martinez S, Wall M, Corbeil T, Andrews H, Castillo F, Neale J, Strang J, Ross S, Comer SD, 2022. A randomized clinical trial of the effects of brief versus extended opioid overdose education on naloxone utilization outcomes by individuals with opioid use disorder. Drug Alcohol Depend 237, 109505. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jurgens K, Bruce M, Ermasova N, Ashmore A, 2024. The safe passages program as approach to combat the heroin epidemic: case of will county, IL. J. Subst. Use 29 (3), 468–472. 10.1080/14659891.2023.2174906. [DOI] [Google Scholar]
- Kaiser Family Foundation, 2018. Beyond health care: the role of social determinants in promoting health and health equity. 〈https://www.kff.org/racial-equity-and-health-policy/issue-brief/beyond-health-care-the-role-of-social-determinants-in-promoting-health-and-health-equity/〉.
- Kelleher KJ, Famelia R, Yilmazer T, Mallory A, Ford J, Chavez LJ, Slesnick N, 2021. Prevention of opioid use disorder: the HOME (housing, opportunities, motivation and engagement) feasibility study. HARM Reduct. J 18 (1). 10.1186/s12954-021-00560-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Khurana D, Leung G, Sasaninia B, Tran D, Khan M, Firek A, 2022. The whole PERSON health score: a patient-focused tool to measure nonmedical determinants of health. NEJM Catal. Innov. Care Deliv 3 (8). CAT-22. [Google Scholar]
- Kiang MV, Barnett ML, Wakeman SE, Humphreys K, Tsai AC, 2021. Robustness of estimated access to opioid use disorder treatment providers in rural vs. Urban areas of the United States. Drug Alcohol Depend 228, 109081. 10.1016/j.drugalcdep.2021.109081. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Knudsen HK, Roman PM, 2014. The transition to medication adoption in publicly funded substance use disorder treatment programs: organizational structure, culture, and resources. J. Stud. Alcohol Drugs 75 (3), 476–485. [DOI] [PMC free article] [PubMed] [Google Scholar]
- LaSane K, Ko C, Dolatshahi J, Nolan ML, Libou M, Barrasse D, Paone D, 2022. Management and staff reception to overdose prevention in NYC nightlife venues. Health Educ. J 81 (4), 413–422. 10.1177/00178969221083081. [DOI] [Google Scholar]
- Lin C, Cousins SJ, Zhu Y, Clingan SE, Mooney LJ, Kan E, Wu F, Hser Y-I, 2024. A scoping review of social determinants of health’s impact on substance use disorders over the life course. J. Subst. Use Addict. Treat 166, 209484. 10.1016/j.josat.2024.209484. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lopez M, Ruiz MO, Rovnaghi CR, 2021. The social ecology of childhood and early life adversity. Pedia Res 89 (2), 353–367. 10.1038/s41390-020-01264-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lott DC, Rhodes J, 2016. Opioid overdose and naloxone education in a substance use disorder treatment program. Am. J. Addict 25 (3), 221–226. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ly J, Peterson D, Geier M, 2024. Evaluating a novel pharmacist-led buprenorphine outreach service for treatment of opioid use disorder in individuals residing in supportive housing (Embase). JACCP J. Am. Coll. Clin. Pharm 7 (2), 115–122. 10.1002/jac5.1915. [DOI] [Google Scholar]
- Mason M, Soliman R, Kim HS, Post LA, 2022. Disparities by sex and race and ethnicity in death rates due to opioid overdose among adults 55 years or older, 1999 to 2019. JAMA Netw. Open 5 (1), e2142982. 10.1001/jamanetworkopen.2021.42982. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McCarthy DM, Curtis LM, Courtney DM, Cameron KA, Lank PM, Kim HS, Opsasnick LA, Lyden AE, Gravenor SJ, Russell AM, Eifler MR, Hur SI, Rowland ME, Walton SM, Montague E, Kim K-YA, Wolf MS, 2019. A multifaceted intervention to improve patient knowledge and safe use of opioids: results of the ED EMC(2) randomized controlled trial. Acad. Emerg. Med 26 (12), 1311–1325. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McElhinny M, Chea K, Carter-Powell A, Mishler A, Bhattarai B, Geren K, 2021. Adult emergency department naloxone education and prescription program: video and pamphlet education comparison. J. Subst. Abus. Treat 127, 108346. [DOI] [PubMed] [Google Scholar]
- McKenzie HA, Dell CA, Fornssler B, 2016. Understanding addictions among indigenous people through social determinants of health frameworks and strength-based approaches: a review of the research literature from 2013 to 2016. Curr. Addict. Rep 3, 378–386. 10.1007/s40429-016-0116-9. [DOI] [Google Scholar]
- Milam AJ, Furr-Holden D, Wang L, Simon KM, 2021. Health data disparities in Opioid-Involved overdose deaths from 1999 to 2018 in the United States. Am. J. Public Health 111 (9), 1627–1635. 10.2105/AJPH.2021.306322. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Morasco BJ, Adams MH, Hooker ER, Maloy PE, Krebs EE, Lovejoy TI, Saha S, Dobscha SK, 2022. A Cluster-Randomized clinical trial to decrease prescription opioid misuse: improving the safety of opioid therapy (ISOT). J. Gen. Intern Med 37 (15), 3805–3813. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Molfenter T, McCarty D, Jacobson N, Kim JS, Starr S, Zehner M, 2019. The payer’s role in addressing the opioid epidemic: It’s more than money. J. subst. abuse treat 101, 72–78. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Munn Z, Peters MDJ, Stern C, Tufanaru C, McArthur A, Aromataris E, 2018. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med. Res. Methodol 18 (1), 143. 10.1186/s12874-018-0611-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- National Institute on Drug Abuse, 2023. 2022–2026 NIDA strategic plan. January 21. 〈https://nida.nih.gov/about-nida/2022-2026-strategic-plan/directors-message〉. January 21.
- National Quality Forum. (2022). Opioid-Related Outcomes Among Individuals With Co-occurring Behavioral Health Conditions. file:///C:/Users/SCousins/Downloads/obh_final_report_2022.pdf
- Novak MD, Holtyn AF, Toegel F, Leoutsakos J-M, Silverman K, 2022. Abstinence-contingent wage supplements to promote drug abstinence and employment: Post-intervention outcomes. Drug Alcohol Depend 232, 109322. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ober AJ, Osilla KC, Klein DJ, Burgette LF, Leamon I, Mazer MW, Messineo G, Collier S, Korouri S, Watkins KE, Ishak W, Nuckols T, Danovitch I, 2023. Pilot randomized controlled trial of a hospital-based substance use treatment and recovery team (START) to improve initiation of medication for alcohol or opioid use disorder and linkage to follow-up care. J. Subst. Use Addict. Treat 150, 209063. 10.1016/j.josat.2023.209063. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Office of Disease Prevention and Health Promotion, 2024. Social determinants of Health—Healthy people 2030 | health.gov. 〈https://health.gov/healthypeople/priority-areas/social-determinants-health〉.
- Ouzzani M, Hammady H, Fedorowicz Z, 2016. Rayyan—A web and mobile app for systematic reviews. Syst. Rev 5, 210. 10.1186/s13643-016-0384-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Palombi L, Olivarez M, Bennett L, Hawthorne AN, 2019. Community forums to address the opioid crisis: an effective grassroots approach to rural community engagement ((Palombi L., lpalombi@d.umn.edu; Olivarez M.; Hawthorne A.N.) Department of Pharmacy Practice and Pharmaceutical Sciences, College of Pharmacy, University of Minnesota, Duluth, MN, United States). Subst. Abus. Res. Treat 13. 10.1177/1178221819827595. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Quanbeck A, Brown RT, Zgierska AE, Jacobson N, Robinson JM, Johnson RA, Deyo BM, Madden L, Tuan W-J, Alagoz E, 2018. A randomized matched-pairs study of feasibility, acceptability, and effectiveness of systems consultation: a novel implementation strategy for adopting clinical guidelines for opioid prescribing in primary care. Implement Sci 13 (1), 21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rangachari P, Govindarajan A, Mehta R, Seehusen D, Rethemeyer RK, 2022. The relationship between social determinants of health (SDoH) and death from cardiovascular disease or opioid use in counties across the United States (2009–2018). BMC PUBLIC HEALTH 22 (1). 10.1186/s12889-022-12653-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rhodes T, Singer M, Bourgois P, Friedman SR, Strathdee SA, 2005. The social structural production of HIV risk among injecting drug users. Social Science Medicine (1982) 61 (5), 1026–1044. 10.1016/j.socscimed.2004.12.024. [DOI] [PubMed] [Google Scholar]
- Schaeffer CM, Swenson CC, Powell JS, 2021. Multisystemic Therapy—Building stronger families (MST-BSF): substance misuse, child neglect, and parenting outcomes from an 18-month randomized effectiveness trial. Child Abus. Negl 122, 105379. [DOI] [PubMed] [Google Scholar]
- Shaffer PM, Rodriguez CP, Gaba A, Byrne T, Casey SC, Harter J, Smelson D, 2021. Engaging vulnerable populations in drug treatment court: six month outcomes from a co-occurring disorder wraparound intervention. Int. J. LAW PSYCHIATRY 76. 10.1016/j.ijlp.2021.101700. [DOI] [PubMed] [Google Scholar]
- Singer M, 2000. A dose of drugs, a touch of violence, a case of AIDS: conceptualizing the SAVA syndemic. Free Inq. Creat. Sociol 28 (1), 13–24. [Google Scholar]
- Smith R, Tran S, Stevens S, Powers J, Gunn M, Nguyen T-M, Franck JB, 2022. Clinical pharmacy initiative to increase naloxone prescribing in patients with opioid use disorder. JACCP J. Am. Coll. Clin. Pharm 5 (2), 174–179. 10.1002/jac5.1568. [DOI] [Google Scholar]
- Spoth R, Trudeau L, Shin C, Redmond C, 2008. Long-term effects of universal preventive interventions on prescription drug misuse. Addiction 103 (7), 1160–1168. 10.1111/j.1360-0443.2008.02160.x. [DOI] [PubMed] [Google Scholar]
- Substance Abuse and Mental Health Services Administration, 2023a. best practices for recovery housing (Nos. PEP23-10-00-002). Substance Abuse and Mental Health Services Administration. 〈https://library.samhsa.gov/sites/default/files/pep23-10-00-002.pdf〉. [Google Scholar]
- Substance Abuse and Mental Health Services Administration, 2023b. The intersection of recovery housing & housing first: a dialogue on collaboration and partnership. Substance Abuse and Mental Health Services Administration. 〈https://www.samhsa.gov/sites/default/files/intersection-recovery-housing-housing-executive-summary.pdf〉. [Google Scholar]
- Substance Abuse and Mental Health Services Administration, 2024. key substance use and mental health indicators in the united states: results from the 2023 national survey on drug use and health (No. HHS Publication No. PEP24-07-021, NSDUH Series H-59). Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. 〈https://www.samhsa.gov/data/sites/default/files/reports/rpt47095/National%20Report/National%20Report/2023-nsduh-annual-national.pdf〉. [Google Scholar]
- Sugarman OK, Bachhuber MA, Wennerstrom A, Bruno T, Springgate BF, 2020. Interventions for incarcerated adults with opioid use disorder in the United States: a systematic review with a focus on social determinants of health. PloS One 15 (1), 0227968. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Suzuki J, Martin B, Loguidice F, Smelson D, Liebschutz JM, Schnipper JL, Weiss RD, 2023. A peer recovery coach intervention for hospitalized patients with opioid use disorder: a pilot randomized controlled trial. J. Addict. Med 17 (5), 604–607. 10.1097/ADM.0000000000001162. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Thornton RL, Glover CM, Cené CW, Glik DC, Henderson JA, Williams DR, 2016. Evaluating Strategies For Reducing Health Disparities By Addressing The Social Determinants Of Health. Health aff. (Project Hope) 35 (8), 1416–1423. 10.1377/hlthaff.2015.1357. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tuten M, Fitzsimons H, Hochheimer M, Jones HE, Chisolm MS, 2018. The impact of early substance use disorder treatment response on treatment outcomes among pregnant women with primary opioid use. J. Addict. Med 12 (4), 300–307. [DOI] [PubMed] [Google Scholar]
- Volkow N, 2023. Social determinants of health can’t be extricated from addiction science. National Institute on Drug Abuse. 〈https://nida.nih.gov/about-nida/noras-blog/2023/04/social-determinants-health-cant-be-extricated-addiction-science〉. [Google Scholar]
- Wagner J, Neitzke-Spruill L, Donnelly EA, O’Connell DJ, Anderson TL, 2021. The current community context of overdose deaths: relations among drug types, drug markets, and socioeconomic neighborhood Characteristics1. Sociol. Forum 36 (4), 1005–1027. 10.1111/socf.12746. [DOI] [Google Scholar]
- Warren JI, Stein JA, Grella CE, 2007. Role of social support and self-efficacy in treatment outcomes among clients with co-occurring disorders. Drug Alcohol Depend 89 (2–3), 267–274. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wenzel K, Fishman M, Wildberger J, Vo H, Burgower R, 2021. An assertive outreach intervention for treatment of opioid use disorder in young adults. Heroin Addict. Relat. Clin. Probl 23 (4), 51–58. [Google Scholar]
- Whitesell M, Bachand A, Peel J, Brown M, 2013. Familial, social, and individual factors contributing to risk for adolescent substance use. J. Addict 2013 (579310). 10.1155/2013/579310. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Whiteside LK, Huynh L, Morse S, Hall J, Meurer W, Banta-Green CJ, Scheuer H, Cunningham R, McGovern M, Zatzick DF, 2021. The emergency department longitudinal integrated care (ED-LINC) intervention targeting opioid use disorder: a pilot randomized clinical trial. J. Subst. Abus. Treat 136, 108666. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Whitman A, De Lew N, Chappel A, Aysola V, Zuckerman R, Sommers BD, 2022. addressing social determinants of health: examples of successful evidence-based strategies and current federal efforts (Report No. HP-2022–12). U.S. Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation. 〈https://aspe.hhs.gov/reports/sdoh-evidence-review〉. [Google Scholar]
- Whittle HJ, Sheira LA, Frongillo EA, 2019. Longitudinal associations between food insecurity and substance use in a cohort of women with or at risk for HIV in the United States. Addiction 114 (1), 127–136. 10.1111/add.14418. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yelton B, Friedman DB, Noblet S, Lohman MC, Arent MA, Macauda MM, Leith KH, 2022. Social determinants of health and depression among African American adults: a scoping review of current research. Int. J. Environ. Res. Public Health 19 (3), 1498. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yoo PY, Duncan GJ, Magnuson K, Fox NA, Yoshikawa H, Halpern-Meekin S, Noble KG, 2022. Unconditional cash transfers and maternal substance use: findings from a randomized control trial of low-income mothers with infants in the US paul. BMC PUBLIC HEALTH 22 (1). 10.1186/s12889-022-12989-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
